From: Hypercalcemia and co-occurring TBX1 mutation in Glycogen Storage Disease Type Ib: case report
Laboratory investigations | Results | Reference value (Unit) |
---|---|---|
CBC | Â | Â |
 Erythrocytes | 3.04 | 3.50–5.50 106 (/µl) |
 Hemoglobin | 9.4 | 12.0–16.0 (g/dl) |
 Hematocrit | 26.8% | 36.0–50.0 (%) |
 Leukocyte | 6.47 | 4.00–10.00 103 (/µl) |
 Neutrophil | 0.65 | 1.50-7.00 103 (/µl) |
 Eosinophils | 0.25 | 0.02–0.50 103 (/µl) |
 Basophils | 0.05 | < 0.06 103 (/µl) |
 Lymphocytes | 4.53 | 1.00–5.00 103 (/µl) |
 Monocytes | 0.99 | 0.15–1.00 103 (/µl) |
 Platelets | 354 | 150–400 103 (/µl) |
Biochemistry tests | Â | Â |
 Glycemia | 0.12 | 0.7–1.10 (g/l) |
 Creatinine | 3.7 | 5–11 (mg/l) |
 Urea | 0.13 | 0.13–0.43 (g/l) |
 Blood calcium | 107 | 84–102 (mg/l) |
 Urine calcium | > 240 | 67–200 (mg/l) |
 AST | 128 | 5–34 (UI/l) |
 ALT | 59 | 0–55 (UI/l) |
 Total Bilirubin | < 1.7 | 3.0–12.0 (mg/l) |
 Conjugated Bilirubin | < 1.0 | 1.0–6.0 (mg/l) |
 Free Bilirubin | < 0.7 | < 1.9 (mg/l) |
 CRP | 8.7 | 0.0–5.0 (mg/l) |
 Triglycerides | 7.1 | < 1.7 (g/l) |
 Albumin | 48 | 27–41 (g/l) |
 Pre-prandial hyperlactatemia | 67 | 5–20 (mg/dl) |
 Post-prandial hyperlactatemia | 83 | 5–20 (mg/dl) |